Scynexis (SCYX) Current Deferred Revenue (2013 - 2026)
Scynexis (SCYX) posted Current Deferred Revenue of $235000.0 for Q1 2026, little changed on a QoQ basis from $235000.0 in Q4 2025, and down 85.69% year-over-year from $1.6 million in Q1 2025.
Scynexis (SCYX) Current Deferred Revenue (2013 - 2026) Analysis & Trends
Scynexis' Current Deferred Revenue history runs 11 years deep, the most recent figure standing at $235000.0 for Q1 2026.
- Quarterly Current Deferred Revenue fell 85.69% year-over-year to $235000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $235000.0 (down 85.69% YoY) and the FY2025 annual result came in at $235000.0, down 85.31% from the prior year.
- Current Deferred Revenue was $235000.0 for Q1 2026 at Scynexis, roughly flat from $235000.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $3.2 million in Q2 2023 and bottomed at $235000.0 in Q4 2025.
- A 4-year average of $1.5 million and a median of $1.6 million in 2024 frame the typical range for Current Deferred Revenue.
- Annual changes were most pronounced in 2025 — Current Deferred Revenue jumped 91.67% — and 2026, when it slumped 85.69%.
- Scynexis' Current Deferred Revenue stood at $1.2 million in 2023, then jumped by 34.57% to $1.6 million in 2024, then sank by 85.31% to $235000.0 in 2025, then changed by 0.0% to $235000.0 in 2026.
- Business Quant data shows SCYX's Current Deferred Revenue at $235000.0 in Q1 2026, $235000.0 in Q4 2025, and $1.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Scynexis | 21.55 Mn | -15.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 235,000.00 |
| Dec 31, 2025 | 235,000.00 |
| Sep 30, 2025 | 1.77 Mn |
| Jun 30, 2025 | 2.30 Mn |
| Mar 31, 2025 | 1.64 Mn |
| Dec 31, 2024 | 1.60 Mn |
| Sep 30, 2024 | 1.64 Mn |
| Jun 30, 2024 | 1.20 Mn |
| Mar 31, 2024 | 1.10 Mn |
| Dec 31, 2023 | 1.19 Mn |
| Sep 30, 2023 | 2.40 Mn |
| Jun 30, 2023 | 3.23 Mn |
| Mar 31, 2019 | 54,000.00 |
| Dec 31, 2018 | 121,000.00 |
| Sep 30, 2018 | 185,000.00 |
| Jun 30, 2018 | 249,000.00 |
| Mar 31, 2018 | 257,000.00 |
| Dec 31, 2017 | 257,000.00 |
| Sep 30, 2017 | 257,000.00 |
| Jun 30, 2017 | 257,000.00 |